| Members |
targetComponentId |
| Breathing problem |
Abnormal breathing (finding) |
| bretyliumtosylat 50 mg/ml, injektionsvätska, lösning, förfylld spruta |
Product containing precisely bretylium 50 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Brevibacterium acetylicum |
Exiguobacterium acetylicum |
| Brevibacterium incertum |
Desemzia incerta (organism) |
| Brevibacterium mecbrellneri |
Brevibacterium mcbrellneri (organism) |
| Brevibacterium oxydans |
Microbacterium oxydans (organism) |
| kort, atonisk anfall |
Atonic seizure (disorder) |
| brimonidin 0,2 %/timolol 0,5 %, ögondroppar |
Product containing precisely brimonidine tartrate 2 milligram/1 milliliter and timolol 5 milligram/1 milliliter conventional release eye solution (clinical drug) |
| bondbönor, livsmedel |
Broad bean (substance) |
| broccoli, livsmedel |
Broccoli (substance) |
| bromelinspecifikt extrakt |
Product containing bromelains (medicinal product) |
| biverkning av bromhexinhydroklorid |
Adverse reaction to bromhexine |
| biverkning av bromkomplex |
Adverse reaction caused by bromine and/or bromine compound (disorder) |
| Bromocriptine [endocrine use] |
Product containing bromocriptine (medicinal product) |
| Bromocriptine [endocrine] |
Product containing bromocriptine (medicinal product) |
| Bromocriptine [parkinsons] |
Product containing bromocriptine (medicinal product) |
| bromodifenhydramin 12,5 mg/5 ml + kodein 10 mg/5 ml, sirap |
Bromazine hydrochloride 2.5 mg/mL and codeine phosphate 2 mg/mL oral solution |
| bromfeniraminmaleat 2 mg + guajfenesin 200 mg + hydrokodonbitartrat 5 mg, sirap |
Brompheniramine maleate 400 microgram/mL and guaifenesin 40 mg/mL and hydrocodone bitartrate 1 mg/mL oral solution |
| bromfeniraminmaleat + pseudoefedrinhydroklorid 16 mg/240 mg, tablett med modifierad frisättning |
Brompheniramine and pseudoephedrine only product in oral dose form |
| bromfeniraminmaleat 16 mg + pseudoefedrinhydroklorid 240 mg, depåtablett |
Brompheniramine and pseudoephedrine only product in oral dose form |
| bromfeniraminmaleat 10 mg/ml, injektionsvätska, lösning, ampull |
Product containing precisely brompheniramine maleate 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| bromfeniraminmaleat 2 mg/5 ml + kodeinfosfat 10 mg/5 ml + fenylpropanolaminhydroklorid 12,5 mg/5 ml, sirap |
Brompheniramine maleate 400 microgram/mL and codeine phosphate 2 mg/mL and phenylpropanolamine hydrochloride 2.5 mg/mL oral solution |
| bromfeniraminmaleat 2 mg/5 ml + dextrometorfanhydrobromid 10 mg/5 ml + fenylpropanolaminhydroklorid 12,5 mg/5 ml, sirap |
Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) |
| bromfeniraminmaleat 2 mg/5 ml + dextrometorfanhydrobromid 10 mg/5 ml + pseudoefedrinhydroklorid 30 mg/5 ml, sirap |
Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and pseudoephedrine hydrochloride 6 mg/mL oral solution |
| bromfeniraminmaleat 4 mg/5 ml + dextrometorfanhydrobromid 15 mg/5 ml + pseudoefedrinhydroklorid 45 mg/5 ml, sirap |
Product containing precisely brompheniramine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 9 milligram/1 milliliter conventional release oral solution (clinical drug) |
| bromfeniraminmaleat 4 mg/5 ml + dextrometorfanhydrobromid 15 mg/5 ml + pseudoefedrinhydroklorid 60 mg/5 ml, sirap |
Brompheniramine 800 microgram/mL and dextromethorphan 3 mg/mL and pseudoephedrine 12 mg/mL oral solution |
| bromfeniraminmaleat 4 mg/5 ml + dextrometorfanhydrobromid 30 mg/5 ml + pseudoefedrinhydroklorid 60 mg/5 ml, sirap |
Brompheniramine 800 microgram/mL and dextromethorphan 6 mg/mL and pseudoephedrine 12 mg/mL oral solution |
| Bromsulfalein |
Sulfobromophthalein |
| Bromsulphalein clearance |
BSP clearance study |
| Bronchioloalveolar adenocarcinoma of lung |
Adenocarcinoma of lung |
| bronkioalveolärt karcinom |
Adenocarcinoma of lung |
| Bronchoscopy with unlisted bronchoscopic procedure |
Bronchoscopy |
| Brucella rangiferi tarandi |
Brucella suis biovar 4 |
| Brucellosis due to other Brucella sp. |
Brucellosis |
| brysselkål, livsmedel |
Brussels sprouts (substance) |
| Bryophyllum |
Genus Kalanchoe (organism) |
| Bryozoan |
Phylum Bryozoa (organism) |
| budesonid 0,5 mg/2 ml, suspension |
Product containing precisely budesonide 250 microgram/1 milliliter conventional release solution for inhalation (clinical drug) |
| budesonid 160 mikrogram + formoterol 4,5 mikrogram, pulverinhalator |
Budesonide 160 microgram and formoterol fumarate dihydrate 4.5 microgram/actuation powder for inhalation |
| budesonid 180 mikrogram, pulver för inhalation |
Product containing only budesonide in pulmonary dose form (medicinal product form) |
| budesonid 1 mg/2 ml, nebulisator |
Product containing precisely budesonide 500 microgram/1 milliliter conventional release solution for inhalation (clinical drug) |
| Budesonide 200mcg/spray powder |
Budesonide 200 microgram/actuation powder for inhalation |
| budesonid 200 mikrogram, inhalationskapsel |
Budesonide 200 microgram/actuation powder for inhalation |
| budesonid 200 mikrogram, inhalator med spacer |
Budesonide 200 microgram/actuation solution for inhalation |
| budesonid 2 mg/100 ml, lavemang |
Product containing only budesonide in rectal dose form (medicinal product form) |
| budesonid 320 mikrogram + formoterol 9 mikrogram, pulverinhalator |
Budesonide and formoterol only product in pulmonary dose form |
| budesonid 400 mikrogram, inhalationskapsel |
Budesonide 400 microgram/actuation powder for inhalation |
| budesonid 500 mikrogram/2 ml, nebulisator |
Product containing precisely budesonide 250 microgram/1 milliliter conventional release solution for inhalation (clinical drug) |
| budesonid 64 mikrogram, vattenbaserad nässprej |
Product containing only budesonide in nasal dose form (medicinal product form) |
| budesonid 64 mikrogram, nässprej |
Product containing only budesonide in nasal dose form (medicinal product form) |
| budesonid 80 mikrogram + formoterol 4,5 mikrogram, pulverinhalator |
Product containing precisely budesonide 80 microgram and formoterol fumarate dihydrate 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug) |
| budesonid 90 mikrogram, pulver för inhalation |
Product containing only budesonide in pulmonary dose form (medicinal product form) |
| budesonid 400 mikrogram + formoterolfumarat 12 mikrogram, andningsaktiverad pulverinhalator |
Budesonide and formoterol only product in pulmonary dose form |
| Bull sheath washing |
Cleaning of prepuce of penis |
| släktet Bullera |
Genus Bullera (organism) |
| Bunyavirus serogroup Bunyamwera |
Bunyamwera virus |
| bupivakain 0,105 %, infusionsvätska, lösning, ampull |
Bupivacaine hydrochloride 1.05 mg/mL solution for injection |
| bupivakain 3,75 mg/ml (0,375 %) injektionsvätska, lösning |
Bupivacaine only product in parenteral dose form |
| Bupivacaine hydrochloride + dextrose 7.5mg/82.5mg injection |
Bupivacaine only product in parenteral dose form |
| bupivakainhydroklorid 0,1 %, infusionsvätska, lösning |
Bupivacaine only product in parenteral dose form |
| bupivakainhydroklorid 0,125 %, infusionsvätska, lösning, påse 250 ml |
Bupivacaine hydrochloride 1.25 mg/mL solution for injection |
| bupivakainhydroklorid 0,5 % + adrenalin 50 mikrogram/10 ml, (1:200 000), för injektion |
Product containing precisely bupivacaine hydrochloride 5 milligram/1 milliliter and epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter conventional release solution for injection (clinical drug) |
| Bupivacaine hydrochloride 0.75% injection |
Bupivacaine only product in parenteral dose form |
| bupivakainhydroklorid 0,75 %, injektionsvätska, lösning, ampull |
Bupivacaine only product in parenteral dose form |
| bupivakainhydroklorid 2,5 mg + adrenalinbitartrat 5 mikrogram, injektionsvätska, lösning, flaska |
Product containing only bupivacaine and epinephrine (medicinal product) |
| bupivakainhydroklorid 5 mg + adrenalin 5 mikrogram, injektionsvätska, lösning, flaska |
Product containing precisely bupivacaine hydrochloride 5 milligram/1 milliliter and epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter conventional release solution for injection (clinical drug) |
| bupivakainhydroklorid 7,5 mg + dextros 82,5 mg, injektionsvätska, lösning, flaska |
Bupivacaine only product in parenteral dose form |
| bupivakainhydroklorid 0,75 % + adrenalin (1:200 000), för injektion |
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and bupivacaine hydrochloride 7.5 mg/mL solution for injection |
| buprenorfin 5 mikrogram per timme, depåplåster |
Product containing only buprenorphine in transdermal dose form (medicinal product form) |
| Buprenorphine hydrochloride + naloxone hydrochloride |
Product containing buprenorphine and naloxone (medicinal product) |
| buprenorfinhydroklorid 2 mg + naloxonhydroklorid 0,5 mg, resoriblett |
Buprenorphine 2 mg and naloxone hydrochloride 500 microgram sublingual tablet |
| buprenorfinhydroklorid 8 mg + naloxonhydroklorid 2 mg, resoriblett |
Buprenorphine (as buprenorphine hydrochloride) 8 mg and naloxone hydrochloride 2 mg sublingual tablet |
| bupropionhydroklorid 100 mg, tablett med modifierad frisättning |
Product containing only bupropion in oral dose form (medicinal product form) |
| bupropionhydroklorid 100 mg, depåtablett |
Product containing only bupropion in oral dose form (medicinal product form) |
| bupropionhydroklorid 200 mg, tablett med modifierad frisättning |
Product containing only bupropion in oral dose form (medicinal product form) |
| bupropionhydroklorid 200 mg, depåtablett |
Product containing only bupropion in oral dose form (medicinal product form) |
| bupropionhydroklorid 300 mg, tablett med modifierad frisättning |
Product containing only bupropion in oral dose form (medicinal product form) |
| bupropionhydroklorid 300 mg, depåtablett |
Product containing only bupropion in oral dose form (medicinal product form) |
| bupropionhydroklorid 50 mg, tablett med modifierad frisättning |
Product containing only bupropion in oral dose form (medicinal product form) |
| bupropionhydroklorid 50 mg, depåtablett |
Product containing only bupropion in oral dose form (medicinal product form) |
| Burkholderia |
Genus Burkholderia (organism) |
| Burkholderia cocovenenans |
Burkholderia gladioli |
| Burkholderia vandii |
Burkholderia plantarii |
| brännskada som engagerar 10-14 procent av kroppsytan, varvid 10-14 procent av kroppsytan är fullhudsbrännskadad |
Burn involving 10-19 percent of body surface, with 10-14 percent of body surface with full thickness burn (disorder) |
| brännskada som engagerar 15-19 procent av kroppsytan, varvid 10-19 procent av kroppsytan är fullhudsbrännskadad |
Burn involving 10-19 percent of body surface, with 15-19 percent of body surface with full thickness burn (disorder) |
| Burn of larynx, trachea AND/OR lung |
Burn |
| Burn of other internal organ, NEC |
Burn of internal organ |
| Burn to cornea - erythema |
Corneal burn |
| Burn to cornea - erythema |
Corneal burn |
| buserelin 150 mikrogram, sprej |
Buserelin only product |
| Buspirone hydrochloride 5mg tablet |
Buspirone hydrochloride 5 mg oral tablet |
| Buspirone hydrochlorine |
Buspirone hydrochloride (substance) |
| butabarbitalnatrium 30 mg/5 ml, elixir |
Product containing precisely secbutabarbital sodium 6 milligram/1 milliliter conventional release oral solution (clinical drug) |
| butorfanoltartrat 1 mg/ml, injektionsvätska, lösning, ampull |
Butorphanol tartrate 1 mg/mL solution for injection |
| butorfanoltartrat 2 mg/ml, injektionsvätska, lösning, ampull |
Butorphanol only product in parenteral dose form |
| butylnitrat, icke läkemedel |
Butyl nitrate |
| antipsykotiskt medel innehållande butyrofenonderivat |
Butyrophenone derivative |
| C/O - specified symptom findings |
Finding reported by subject or history provider (finding) |
| C1-esterashämmare 500 enheter, pulver till injektionsvätska, lösning, injektionsflaska 8 ml |
Product containing precisely human C1 esterase inhibitor 500 unit/1 vial powder for conventional release solution for injection (clinical drug) |
| CDC Corynebacterium group G-1 |
Corynebacterium accolens |
| CDC group DF-2 |
Capnocytophaga canimorsus |
FHIR